Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 17.49 -0.33 (-1.85%) Market Cap: 473.92 Mil Enterprise Value: 252.44 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 74/100

Arcturus Therapeutics Holdings Inc Annual Shareholders Meeting Transcript

Jun 21, 2022 / 04:00PM GMT
Release Date Price: $14.56 (+8.09%)
Joseph E. Payne
Arcturus Therapeutics Holdings Inc. - Founder, President, CEO & Director

Good morning, and welcome to the 2022 Annual Meeting of Stockholders of Arcturus Therapeutics Holdings, Inc. Due to the ongoing COVID-19 pandemic, we are holding this year's annual meeting as an entirely virtual meeting. Stockholders who require technical assistance during the meeting can call Continental's technical support line at the phone number posted on the meeting login page.

I'm Joe Payne, the President and CEO as well as a member of the Board of Directors. It is now 9:00 a.m. Pacific Time on June 21, 2022, and this meeting will please come to order. Also participating in this meeting are Dr. Padmanabh Chivukula, our Chief Scientific Officer and Chief Operating Officer of the company; Mr. Jeffrey Baumel and Mr. Grant Levine of Dentons US LLP, counsel to the company; Keri-Ann Cuadros of Continental Stock Transfer & Trust Company, who has been appointed as inspector of election for the meeting; and Brian Valenzuela of Ernst & Young LLP, independent registered accountants of the company.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot